Seeing Is Believing
MYNZ is currently covered by 2 analysts with an average price target of $12.17. This is a potential upside of $4.85 (66.26%) from yesterday's end of day stock price of $7.32.
Mainz Biomed BV's activity chart (see below) currently has 0 price targets and 14 ratings on display. The stock rating distribution of MYNZ is 92.86% BUY and 7.14% HOLD.
Highest price target for MYNZ is $10, Lowest price target is $1, average price target is $12.17.
Most recent stock forecast was given by ROSS OSBORN from CANTOR FITZGERALD on 21-Nov-2023. First documented stock forecast 21-Jun-2022.
Currently out of the existing stock ratings of MYNZ, 13 are a BUY (92.86%), 1 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$9
1 years 14 days ago
(21-Nov-2023)
0/5 (0%)
$5.85 (185.71%)
Buy
$5
$3.92 (362.96%)
$9
1 years 15 days ago
(20-Nov-2023)
0/8 (0%)
$3.84 (331.03%)
What is MYNZ (Mainz Biomed BV) average time for price targets to be met?
Which analyst has the current highest performing score on MYNZ (Mainz Biomed BV) with a proven track record?
Which analyst has the current lower performing score on MYNZ (Mainz Biomed BV) with a proven track record?
Which analyst has the most public recommendations on MYNZ (Mainz Biomed BV)?
Which analyst is the currently most bullish on MYNZ (Mainz Biomed BV)?
Which analyst is the currently most reserved on MYNZ (Mainz Biomed BV)?